BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30755593)

  • 1. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
    Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
    Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
    Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
    Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
    Lee S; Youn K; Lim G; Lee J; Jun M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
    Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
    Matošević A; Opsenica DM; Spasić M; Maraković N; Zandona A; Žunec S; Bartolić M; Kovarik Z; Bosak A
    Chem Biol Interact; 2023 Sep; 382():110620. PubMed ID: 37406982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.
    Nuthakki VK; Sharma A; Kumar A; Bharate SB
    Drug Dev Res; 2019 Aug; 80(5):655-665. PubMed ID: 31050027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ovalbumin-derived peptides as multi-target inhibitors of AChE, BChE, and BACE1.
    Yu Z; Dong W; Wu S; Shen J; Zhao W; Ding L; Liu J; Zheng F
    J Sci Food Agric; 2020 Apr; 100(6):2648-2655. PubMed ID: 31997357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalein as a Potential Inhibitor against BACE1 and AChE: Mechanistic Comprehension through In Vitro and Computational Approaches.
    Han J; Ji Y; Youn K; Lim G; Lee J; Kim DH; Jun M
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and Molecular Docking Studies of 6-Formyl Umbelliferone Isolated from Angelica decursiva as an Inhibitor of Cholinesterase and BACE1.
    Ali MY; Seong SH; Reddy MR; Seo SY; Choi JS; Jung HA
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28946641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure Related Inhibition of Enzyme Systems in Cholinesterases and BACE1 In Vitro by Naturally Occurring Naphthopyrone and Its Glycosides Isolated from Cassia obtusifolia.
    Shrestha S; Seong SH; Paudel P; Jung HA; Choi JS
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29283428
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of the Antioxidant and Anti-Alzheimer's Disease Potential of Coumestrol and Puerarol Isolated from Pueraria lobata Using Molecular Modeling Studies.
    Koirala P; Seong SH; Jung HA; Choi JS
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29597336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L.
    Kuk EB; Jo AR; Oh SI; Sohn HS; Seong SH; Roy A; Choi JS; Jung HA
    Arch Pharm Res; 2017 Mar; 40(3):338-349. PubMed ID: 28093699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
    Abdullaha M; Nuthakki VK; Bharate SB
    Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.